These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12777990)

  • 1. Standard reference material for Her2 testing: report of a National Institute of Standards and Technology-sponsored Consensus Workshop.
    Hammond ME; Barker P; Taube S; Gutman S
    Appl Immunohistochem Mol Morphol; 2003 Jun; 11(2):103-6. PubMed ID: 12777990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing a cell line standard for HER2/neu.
    Rhodes A
    Cancer Biomark; 2005; 1(4-5):229-32. PubMed ID: 17192046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External quality assurance of HER2 FISH and ISH testing: three years of the UK national external quality assurance scheme.
    Bartlett JM; Ibrahim M; Jasani B; Morgan JM; Ellis I; Kay E; Connolly Y; Campbell F; O'Grady A; Barnett S; Miller K
    Am J Clin Pathol; 2009 Jan; 131(1):106-11. PubMed ID: 19095573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HER2 testing in gastric cancer: results of a German expert meeting.
    Lordick F; Al-Batran SE; Dietel M; Gaiser T; Hofheinz RD; Kirchner T; Kreipe HH; Lorenzen S; Möhler M; Quaas A; Röcken C; Rüschoff J; Tannapfel A; Thuss-Patience P; Baretton G
    J Cancer Res Clin Oncol; 2017 May; 143(5):835-841. PubMed ID: 28285403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HER2 testing in breast carcinoma: very low concordance rate between reference and local laboratories in Brazil.
    Wludarski SC; Lopes LF; Berto E Silva TR; Carvalho FM; Weiss LM; Bacchi CE
    Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):112-8. PubMed ID: 20930616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. College of American Pathologists' laboratory standards for next-generation sequencing clinical tests.
    Aziz N; Zhao Q; Bry L; Driscoll DK; Funke B; Gibson JS; Grody WW; Hegde MR; Hoeltge GA; Leonard DG; Merker JD; Nagarajan R; Palicki LA; Robetorye RS; Schrijver I; Weck KE; Voelkerding KV
    Arch Pathol Lab Med; 2015 Apr; 139(4):481-93. PubMed ID: 25152313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic kits in parasitology: which controls?].
    Rossi P
    Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory compliance with the American Society of Clinical Oncology/College of American Pathologists human epidermal growth factor receptor 2 testing guidelines: a 3-year comparison of validation procedures.
    Dyhdalo KS; Fitzgibbons PL; Goldsmith JD; Souers RJ; Nakhleh RE
    Arch Pathol Lab Med; 2014 Jul; 138(7):876-84. PubMed ID: 24978913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Notice for American Society of Clinical Oncology-College of American Pathologists guideline recommendations on ER/PgR and HER2 testing in breast cancer.
    Hammond ME; Hayes DF; Wolff AC
    J Clin Oncol; 2011 May; 29(15):e458. PubMed ID: 21502545
    [No Abstract]   [Full Text] [Related]  

  • 10. HER2 testing: current status and future directions.
    Perez EA; Cortés J; Gonzalez-Angulo AM; Bartlett JM
    Cancer Treat Rev; 2014 Mar; 40(2):276-84. PubMed ID: 24080154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Summary of the National Institute of Standards and Technology and US Food And Drug Administration cell counting workshop: Sharing practices in cell counting measurements.
    Lin-Gibson S; Sarkar S; Elliott JT
    Cytotherapy; 2018 Jun; 20(6):785-795. PubMed ID: 29699860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations.
    Sauter G; Lee J; Bartlett JM; Slamon DJ; Press MF
    J Clin Oncol; 2009 Mar; 27(8):1323-33. PubMed ID: 19204209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The how and why of an accuracy base for proficiency testing programs.
    Welch MJ; Hertz HS
    Arch Pathol Lab Med; 1988 Apr; 112(4):343-5. PubMed ID: 3355329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of DNA typing on standards and practice in the forensic community.
    Reeder DJ
    Arch Pathol Lab Med; 1999 Nov; 123(11):1063-5. PubMed ID: 10539909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemistry validation procedures and practices: a College of American Pathologists survey of 727 laboratories.
    Hardy LB; Fitzgibbons PL; Goldsmith JD; Eisen RN; Beasley MB; Souers RJ; Nakhleh RE
    Arch Pathol Lab Med; 2013 Jan; 137(1):19-25. PubMed ID: 23276171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commutability of National Institute of Standards and Technology standard reference material 1955 homocysteine and folate in frozen human serum for total folate with automated assays.
    Ihara H; Watanabe T; Hashizume N; Totani M; Kamioka K; Onda K; Sunahara S; Suzuki T; Itabashi M; Aoki Y; Ishibashi M; Ito S; Ohashi K; Enomoto T; Saito K; Saeki K; Nagamura Y; Nobori T; Hirota K; Fujishiro K; Maekawa M; Miura M; Ohta Y
    Ann Clin Biochem; 2010 Nov; 47(Pt 6):541-8. PubMed ID: 20926465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer biomarkers and HER2 testing after 10 years of anti-HER2 therapy.
    Ross JS
    Drug News Perspect; 2009 Mar; 22(2):93-106. PubMed ID: 19330168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program. An approach to accurate and precise lipid measurements.
    Myers GL; Cooper GR; Winn CL; Smith SJ
    Clin Lab Med; 1989 Mar; 9(1):105-35. PubMed ID: 2538292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Droplet Digital™ PCR quantitation of HER2 expression in FFPE breast cancer samples.
    Heredia NJ; Belgrader P; Wang S; Koehler R; Regan J; Cosman AM; Saxonov S; Hindson B; Tanner SC; Brown AS; Karlin-Neumann G
    Methods; 2013 Jan; 59(1):S20-3. PubMed ID: 23036330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of the Australian in situ hybridization program for the assessment of HER2 amplification in breast cancer: a model for the introduction of new biomarkers into clinical practice.
    Farshid G; Armes JE; Bell R; Cummings M; Fox S; Francis G; Haswell M; Morey A; McCue G; Raymond W; Robbins P; Bilous M
    Diagn Mol Pathol; 2010 Dec; 19(4):187-93. PubMed ID: 21052003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.